ProDisc-C total disc arthroplasty vs ACDF in single-level cervical disc disease at 7 years
ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption StudyJ Bone Joint Surg Am. 2015 Nov 4;97(21):1738-47
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
209 patients with single-level cervical degenerative disc disease were randomized to undergo either anterior cervical discectomy and fusion (ACDF) or total disc arthroplasty (with ProDisc-C). The purpose of this randomized controlled trial was to report the 7-year efficacy and safety outcomes of an FDA Investigational Device Exemption randomized controlled trial. The results at both 2 and 7 years ...
Join the Conversation
Please Login or Join to leave comments.